Default company panoramic image

Vivorte, Inc

Vivorte has two innovative orthopedic technologies in their pipeline. The first a combination synthetic/biologic bone void filler has received FDA clearance.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Louisville, KY, USA
  • Currency USD
  • Founded April 2007
  • Employees 7
  • Incorporation Type C-corp
  • Website

Company Summary

Vivorte's mission is to identify, develop and commercialize orthopedic devices which address unmet needs in markets exceeding $1B. We have 2 products: a minimally invasive implantable device designed to treat osteoporosis & hip fractures and a synthetic/biologic bone void filler (BVF) which is both strong and remodels. We have achieved revenue with the BVF and are discussing a distribution/licensing deal with an established company.


  • Default avatar
    Ruth Ann Voor

    Ruth is a 1983 graduate of the US Naval Academy. During her Navy tenure Ruth received numerous leadership awards including Service Warfare Officer Qualification. She joined J&J in 1989 starting in operations and R&D and culminated this phase of her career by successfully bringing the first drug eluting stent to market: CYHPER™. She then transferred to strategic marketing and worked with identifying L&A opportunities for the portfolio.

  • Default avatar
    Michael John Voor
    Chief Scientific Officer

    Dr. Michael Voor (Vivorté CSO) is Director of the Orthopaedic Bioengineering Laboratory at the University of Louisville. He received his Ph.D. in Biomedical Engineering from Tulane University. He has secured over $2M in research funding from various sources including Whitaker, NSF, NIH, and orthopaedic industry; has over 55 peer-reviewed publications; and authored several patents. His lab focuses on the study of bone and orthopaedic devices

  • Default avatar
    Stephen J Peoples
    Regulatory Consultant

    Dr. Stephen J. Peoples, President of Peoples & Associates, serves as Vivorte’s regulatory & quality consultant. Dr. Peoples has more than 30 years experience including 24 years at DePuy, Inc., where he served in a number of senior executive management positions including Worldwide Vice President positions in Clinical Research and Regulatory Affairs; Quality Systems; Compliance; Healthcare Economics and Reimbursement; and Medical Affairs.


  • Default avatar
    Frost Brown Todd; William Strench
    Default avatar
    OPM; Chuck Woods